Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock (NASDAQ: ACRV) is trading at $2.08, about ₹200 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, up 0.97% today. Indian residents can buy Acrivon Therapeutics, Inc. Common Stock from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$2.05
Today's high
$2.13
52 week low
$1.27
52 week high
$3.56
ACRV opened at $2.07, closed previously at $2.06, and has traded between $1.27 and $3.56 over the past 52 weeks.
About
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Key statistics
Avg. volume
385.50K
Market cap
$89.03M
P/E Ratio
-1.11
Price-to-sales ratio
0.00
Enterprise value
$54.02M
Free cash flow yield
-70.40%
Debt-to-equity ratio
0.02
Return on equity
-69.24%
ROIC
-73.00%
Beta
1.93
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$0.00
Earnings per share
-$2.02
Free cash flow
-$65.33M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-$76.55M
Revenue growth
0.00%
Similar securities
This is not an investment recommendation
How to buy Acrivon Therapeutics, Inc. Common Stock from India
Indian residents can buy Acrivon Therapeutics, Inc. Common Stock shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Acrivon Therapeutics, Inc. Common Stock and place an order
Find Acrivon Therapeutics, Inc. Common Stock by name or by its ticker, ACRV, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Acrivon Therapeutics, Inc. Common Stock trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Acrivon Therapeutics, Inc. Common Stock position in USD and INR. Acrivon Therapeutics, Inc. Common Stock pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Acrivon Therapeutics, Inc. Common Stock from India
Trading and taxes when buying Acrivon Therapeutics, Inc. Common Stock from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneAcrivon Therapeutics, Inc. Common Stock does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Acrivon Therapeutics, Inc. Common Stock stock?
Yes. Acrivon Therapeutics, Inc. Common Stock (ACRV) has been listed on NASDAQ since 2022, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Acrivon Therapeutics, Inc. Common Stock share cost in rupees?
One Acrivon Therapeutics, Inc. Common Stock share is $2.08 — about ₹200 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Acrivon Therapeutics, Inc. Common Stock price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Acrivon Therapeutics, Inc. Common Stock from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Acrivon Therapeutics, Inc. Common Stock?
Yes. One Acrivon Therapeutics, Inc. Common Stock share is $2.08, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Acrivon Therapeutics, Inc. Common Stock.
How are gains on Acrivon Therapeutics, Inc. Common Stock shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Acrivon Therapeutics, Inc. Common Stock price. Paasa issues a capital-gains statement for your return.
Does Acrivon Therapeutics, Inc. Common Stock pay a dividend?
No. Acrivon Therapeutics, Inc. Common Stock does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Acrivon Therapeutics, Inc. Common Stock from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Acrivon Therapeutics, Inc. Common Stock shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Acrivon Therapeutics, Inc. Common Stock shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Acrivon Therapeutics, Inc. Common Stock holding, its cost and its closing value.
How do I sell Acrivon Therapeutics, Inc. Common Stock and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.